Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-031055

Director sold 7,500 shares at $74.65 ($559,875)

  • Director acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Aliski William · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-18 Exercise or conversion : show line 1 in the form +7,500 $40.37 $302,775 55,424 D
2020-05-18 Sale : show line 2 in the form −7,500 $74.65 $559,875 47,924 D
Open-market sales · 7,500 sh · avg $74.65 · $559,875

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-05-18 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −7,500 $40.37 2024-07-10 7,500 0 D
Loading xslF345X03/doc4.xml…